BioSpace News Archive

Abeona Therapeutics Inc. announced it has granted equity awards to new non-executive employees who joined the Company.

908 Devices Inc., a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, reported financial results for the quarter and full year ended December 31, 2023.

LAVA Therapeutics N.V., a clinical-stage immuno-oncology company focused on developing its proprietary Gammabody® platform of bispecific gamma delta T cell engagers, announced that Pfizer has achieved a clinical development milestone for PF-08046052, prompting the first milestone payment of $7 Million to LAVA.

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on Tuesday, March 12th, 2024.

Mereo BioPharma Group plc announced that Dr. Denise Scots-Knight, Chief Executive Officer, will participate in a Fireside Chat at the Leerink Partners Global Biopharma Conference on Tuesday, March 12, 2024 at 11:20am ET / 03:20pm GMT.

Relmada Therapeutics, Inc. today announced that they will participate in the Leerink Partners Global Biopharma Conference.

Researchers from Invitae, a leading medical genetics company, are showcasing their work next week at the 2024 American College of Medical Genetics and Genomics Annual Clinical Genetics Meeting in Toronto, Canada from March 12-16.

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced that the KARDIA-2 Phase 2 study of zilebesiran, an investigational RNAi therapeutic targeting liver-expressed angiotensinogen (AGT).

Oragenics, Inc., a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, announced it is preparing to undertake the final steps of GMP manufacturing and formulation of its drug candidate for its expected Phase IIA clinical trial.

Gossamer Bio, Inc. today announced its financial results for the fourth quarter and year ended December 31, 2023, and provided a business update.